Literature DB >> 26869655

ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.

Caitriona B O'Neill1, Coral L Atoria1, Eileen M O'Reilly1, Martin C Henman1, Peter B Bach1, Elena B Elkin2, Caitriona B O'Neill1, Coral L Atoria1, Eileen M O'Reilly1, Martin C Henman1, Peter B Bach1, Elena B Elkin2.   

Abstract

PURPOSE: Hospital readmissions are often cited as a marker of poor quality of care. Limited data suggest some readmissions may be preventable depending upon definitions and available outpatient support.
METHODS: General criteria to define preventable and not preventable admissions were developed before data collection began. The records of sequential nonsurgical oncology readmissions were reviewed independently by two reviewers. When the reviewers disagreed about assigning admissions as preventable or not preventable, a third reviewer was the tie breaker. The reasons for assigning admissions as preventable or not preventable were analyzed.
RESULTS: Seventy-two readmissions occurring among 69 patients were analyzed. The first two reviewers agreed that 18 (25%) of 72 were preventable and that 29 (40%) of 72 were not. A third reviewer found four of the split 25 cases to be preventable; therefore, the consensus preventability rate was 22 (31%) of 72. The most common causes of preventability were overwhelming symptoms in patients who qualified for hospice but were not participating in hospice and insufficient communication between patients and the care team about symptom burden. The most common reason for assignment of a not preventable admission was a high symptom burden among patients without strong indications for hospice or for whom aggressive outpatient management was inadequate. The median survival after readmission was 72 days.
CONCLUSION: A substantial proportion of oncology readmissions could be prevented with better anticipation of symptoms in high-risk ambulatory patients and enhanced communication about symptom burden between patients and physicians before an escalation that leads to an emergency department visit. Managing symptoms in patients who are appropriate for hospice is challenging. Readmission is a marker of poor prognosis.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 26869655      PMCID: PMC5702789          DOI: 10.1200/JOP.2015.004812

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  44 in total

1.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

2.  NCCN clinical practice guidelines in oncology: multiple myeloma.

Authors:  Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Adam D Cohen; Steven Devine; Benjamin Djulbegovic; Cristina Gasparetto; Carol Ann Huff; Madan Jagasia; Bruno C Medeiros; Ruby Meredith; Noopur Raje; Jeffrey Schriber; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Guido Tricot; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
Journal:  J Natl Compr Canc Netw       Date:  2009-10       Impact factor: 11.908

3.  Regional variation in spending and survival for older adults with advanced cancer.

Authors:  Gabriel A Brooks; Ling Li; Dhruv B Sharma; Jane C Weeks; Michael J Hassett; K Robin Yabroff; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2013-03-12       Impact factor: 13.506

4.  Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.

Authors:  Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

5.  Benchmarks for value in cancer care: an analysis of a large commercial population.

Authors:  Michael Kolodziej; J Russell Hoverman; Jody S Garey; Janet Espirito; Sheetal Sheth; Aimee Ginsburg; Marcus A Neubauer; Debra Patt; Barry Brooks; Charles White; Mark Sitarik; Roger Anderson; Roy Beveridge
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

6.  The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study.

Authors:  Carla N Holcomb; Laura A Graham; Joshua S Richman; Kamal M F Itani; Thomas M Maddox; Mary T Hawn
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

7.  Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada.

Authors:  Thi H Ho; Lisa Barbera; Refik Saskin; Hong Lu; Bridget A Neville; Craig C Earle
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

8.  The use of the propensity score for estimating treatment effects: administrative versus clinical data.

Authors:  Peter C Austin; Muhammad M Mamdani; Therese A Stukel; Geoffrey M Anderson; Jack V Tu
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

9.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

10.  Chemotherapy use among Medicare beneficiaries at the end of life.

Authors:  Ezekiel J Emanuel; Yinong Young-Xu; Norman G Levinsky; Gail Gazelle; Olga Saynina; Arlene S Ash
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

View more
  10 in total

1.  Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy.

Authors:  Grace Lu-Yao; Ginah Nightingale; Nikita Nikita; Scott Keith; Krupa Gandhi; Kristine Swartz; Ralph Zinner; Swapnil Sharma; W M Kevin Kelly; Andrew Chapman
Journal:  J Geriatr Oncol       Date:  2020-03-19       Impact factor: 3.599

2.  Treatment-Related Complications of Systemic Therapy and Radiotherapy.

Authors:  Vikram Jairam; Victor Lee; Henry S Park; Charles R Thomas; Edward R Melnick; Cary P Gross; Carolyn J Presley; Kerin B Adelson; James B Yu
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

3.  Creating and Validating a Predictive Model for Suitability of Hospital at Home for Patients With Solid-Tumor Malignancies.

Authors:  Kevin Chen; Keval Desai; Soundari Sureshanand; Kerin Adelson; Jeremy I Schwartz; Cary P Gross; Sarwat I Chaudhry
Journal:  JCO Oncol Pract       Date:  2021-01-08

4.  Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy.

Authors:  Heidi D Klepin; Can-Lan Sun; David D Smith; Rawad Elias; Kelly M Trevino; Ashley Leak Bryant; Daneng Li; Christian Nelson; William P Tew; Supriya G Mohile; Ajeet Gajra; Cynthia Owusu; Cary Gross; Stuart M Lichtman; Vani V Katheria; Hyman B Muss; Andrew E Chapman; Harvey Jay Cohen; Arti Hurria; William Dale
Journal:  JCO Oncol Pract       Date:  2021-04-21

5.  Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.

Authors:  Anish B Parikh; Xiaobo Zhong; George Mellgard; Qian Qin; Vaibhav G Patel; Bo Wang; Parissa Alerasool; Philip Garcia; Amanda Leiter; Emily J Gallagher; Steven Clinton; Amir Mortazavi; Paul Monk; Edmund Folefac; Ming Yin; Yuanquan Yang; Matthew Galsky; William K Oh; Che-Kai Tsao
Journal:  Am J Clin Oncol       Date:  2021-03-01       Impact factor: 2.787

6.  Hospitalizations and length of stay of cancer patients: A cohort study in the Brazilian Public Health System.

Authors:  Flávia Feliciana Silva; Gisele Macedo da Silva Bonfante; Ilka Afonso Reis; Hugo André da Rocha; Agner Pereira Lana; Mariangela Leal Cherchiglia
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

7.  Trends in Hospital Admissions Due to Neoplasms in England and Wales between 1999 and 2019: An Ecological Study.

Authors:  Abdallah Y Naser; Hassan Alwafi; Sara Ibrahim Hemmo; Hamzeh Mohammad Alrawashdeh; Jaber S Alqahtani; Saeed M Alghamdi; Moaath K Mustafa Ali
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

8.  Management and survival analysis of elderly patients with a cancer in the digestive system who refused to receive anticancer treatments.

Authors:  Jun Wan; Shiping Xu; Yinqiao Wu; Benyan Wu; Dezhong Joshua Liao; Ningzhi Xu; Gangshi Wang
Journal:  Support Care Cancer       Date:  2018-02-07       Impact factor: 3.603

9.  Socio-demographic and disease related characteristics associated with unplanned emergency department visits by cancer patients: a retrospective cohort study.

Authors:  Polly H Dufton; Allison Drosdowsky; Marie F Gerdtz; Mei Krishnasamy
Journal:  BMC Health Serv Res       Date:  2019-09-06       Impact factor: 2.655

10.  Age Is Not a Barrier: Older Adults With Cancer Derive Similar Benefit in a Randomized Controlled Trial of a Remote Symptom Monitoring Intervention Compared With Younger Adults.

Authors:  Lorinda A Coombs; Lee Ellington; Angela Fagerlin; Kathi Mooney
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.